Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.65 |
| ▸ | CA2 | P00918 | 1/20 | 0.65 |
| ▸ | CA4 | P22748 | 1/20 | 0.65 |
| ▸ | LSS | P48449 | 2/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | GBA1 | P04062 | 4/20 | 0.39 |
| ▸ | GUSB | P08236 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.37 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.37 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.37 |
| ▸ | GLB1 | P16278 | 3/20 | 0.36 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1391670 | 1.00 | CA1 (0.65) | CA1CA2CA4LSSALOX5 | |
| SCHEMBL669599 | 1.00 | CA1 (0.65) | CA1CA2CA4LSSALOX5 | |
| SCHEMBL30879546 | 1.00 | CA1 (0.65) | CA1CA2CA4LSSALOX5 | |
| SCHEMBL16766705 | 0.98 | CA1 (0.63) | CA1CA2CA4LSSALOX5 | |
| SCHEMBL16766627 | 0.98 | CA1 (0.63) | CA1CA2CA4LSSALOX5 | |
| SCHEMBL23542639 | 0.98 | CA1 (0.63) | CA1CA2CA4LSSALOX5 | |
| SCHEMBL19338297 | 0.98 | CA1 (0.63) | CA1CA2CA4LSSALOX5 | |
| SCHEMBL8754572 | 0.96 | CA1 (0.72) | CA1CA2CA4LSSALOX5 | |
| SCHEMBL8754576 | 0.96 | CA1 (0.72) | CA1CA2CA4LSSALOX5 | |
| SCHEMBL5557539 | 0.96 | CA1 (0.72) | CA1CA2CA4LSSALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250186646-A1 | Use of Volatile Compositions to Limit or Eliminate Perception of Fecal Malodour | FIRMENICH SA (CH) | 2025-06-12 | — | — | US | disclosed |
| EP-3689849-B1 | PERFUME PRECURSOR | TAKASAGO PERFUMERY CO LTD (JP) | 2025-01-15 | — | — | EP | disclosed |
| EP-4218837-B1 | VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | FIRMENICH & CIE (CH) | 2024-11-27 | — | — | EP | disclosed |
| EP-3443988-B1 | COMPOSITION AND USE OF COMPOSITION FOR COUNTERACTING AMMONIA MALODOR | FIRMENICH & CIE (CH) | 2024-04-17 | — | — | EP | disclosed |
| EP-4338761-A1 | PERFUMING COMPOSITIONS | Firmenich SA (CH) | 2024-03-20 | — | — | EP | disclosed |
| US-11802258-B2 | Perfume precursor | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-10-31 | — | — | US | disclosed |
| US-11744785-B2 | Use of volatile compositions to limit or eliminate the perception of malodor | FIRMENICH SA (CH) | 2023-09-05 | — | — | US | disclosed |
| EP-3541435-B1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | FIRMENICH & CIE (CH) | 2023-08-30 | — | — | EP | disclosed |
| EP-4218837-A1 | VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | Firmenich SA (CH) | 2023-08-02 | — | — | EP | disclosed |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2023-07-27 | — | — | US | disclosed |
| WO-2011033410-A1 | NITRILE COMPOUNDS AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2011-03-24 | — | — | WO | disclosed |
| US-20100291016-A1 | PERFUMING INGREDIENTS IMPARTING SAP AND/OR EARTHY TYPE NOTES | FIRMENICH (CH) | 2010-11-18 | — | — | US | disclosed |
| WO-2010122451-A1 | ACETALS AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2010-10-28 | — | — | WO | disclosed |
| EP-2234948-A1 | PERFUMING INGREDIENTS IMPARTING SAP AND/OR EARTHY TYPE NOTES | Firmenich S.A. (CH) | 2010-10-06 | — | — | EP | disclosed |
| US-7767639-B2 | Unsaturated ethers as perfuming ingredients | FIRMENICH SA (CH) | 2010-08-03 | — | — | US | disclosed |
| WO-2009093175-A1 | PERFUMING INGREDIENTS IMPARTING SAP AND/OR EARTHY TYPE NOTES | FIRMENICH SA (CH) | 2009-07-30 | — | — | WO | disclosed |
| EP-1784374-B1 | UNSATURATED ETHERS AS PERFUMING INGREDIENTS | FIRMENICH & CIE (CH) | 2008-03-05 | — | — | EP | disclosed |
| EP-1784374-A2 | UNSATURATED ETHERS AS PERFUMING INGREDIENTS | Firmenich SA (CH) | 2007-05-16 | — | — | EP | disclosed |
| US-20070087956-A1 | UNSATURATED ETHERS AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2007-04-19 | — | — | US | disclosed |
| WO-2006021857-A2 | UNSATURATED ETHERS AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2006-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11744785-B2 | Use of volatile compositions to limit or eliminate the perception of malodor | TAS2R8, TRPA1, TAS2R10 | CA1 4530/4885CA2 1444/4885CA4 1031/4885 |
| US-11802258-B2 | Perfume precursor | CYP2E1, ADH1A, CYP1A1 | CA1 3362/4885CA2 3624/4885CA4 2989/4885 |
| US-20100291016-A1 | PERFUMING INGREDIENTS IMPARTING SAP AND/OR EARTHY TYPE NOTES | ACLY, PPOX, CAPRIN1 | CA1 2082/4885CA2 2107/4885CA4 1417/4885 |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | TAS2R8, TRPA1, TAS2R10 | CA1 4530/4885CA2 1444/4885CA4 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.